1. Home
  2. CMPX vs CVEO Comparison

CMPX vs CVEO Comparison

Compare CMPX & CVEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPX
  • CVEO
  • Stock Information
  • Founded
  • CMPX 2014
  • CVEO 1977
  • Country
  • CMPX United States
  • CVEO United States
  • Employees
  • CMPX N/A
  • CVEO N/A
  • Industry
  • CMPX Biotechnology: Pharmaceutical Preparations
  • CVEO Hotels/Resorts
  • Sector
  • CMPX Health Care
  • CVEO Consumer Discretionary
  • Exchange
  • CMPX Nasdaq
  • CVEO Nasdaq
  • Market Cap
  • CMPX 291.8M
  • CVEO 283.8M
  • IPO Year
  • CMPX N/A
  • CVEO N/A
  • Fundamental
  • Price
  • CMPX $3.44
  • CVEO $23.40
  • Analyst Decision
  • CMPX Strong Buy
  • CVEO Strong Buy
  • Analyst Count
  • CMPX 8
  • CVEO 1
  • Target Price
  • CMPX $13.50
  • CVEO $27.00
  • AVG Volume (30 Days)
  • CMPX 1.4M
  • CVEO 61.7K
  • Earning Date
  • CMPX 08-11-2025
  • CVEO 10-29-2025
  • Dividend Yield
  • CMPX N/A
  • CVEO 2.14%
  • EPS Growth
  • CMPX N/A
  • CVEO N/A
  • EPS
  • CMPX N/A
  • CVEO N/A
  • Revenue
  • CMPX N/A
  • CVEO $634,027,000.00
  • Revenue This Year
  • CMPX N/A
  • CVEO N/A
  • Revenue Next Year
  • CMPX N/A
  • CVEO $3.59
  • P/E Ratio
  • CMPX N/A
  • CVEO N/A
  • Revenue Growth
  • CMPX N/A
  • CVEO N/A
  • 52 Week Low
  • CMPX $1.27
  • CVEO $18.01
  • 52 Week High
  • CMPX $4.08
  • CVEO $28.92
  • Technical
  • Relative Strength Index (RSI)
  • CMPX 62.85
  • CVEO 50.59
  • Support Level
  • CMPX $3.29
  • CVEO $22.82
  • Resistance Level
  • CMPX $3.52
  • CVEO $24.06
  • Average True Range (ATR)
  • CMPX 0.18
  • CVEO 0.54
  • MACD
  • CMPX 0.04
  • CVEO 0.06
  • Stochastic Oscillator
  • CMPX 81.68
  • CVEO 72.41

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

About CVEO Civeo Corporation (Canada)

Civeo Corp provides hospitality services to the natural resources industry in Canada, Australia and the United States. The company provides a full suite of services for guests, including lodging, catering and food service, housekeeping and maintenance at accommodation facilities that the company or its customers own. The company provides services that support the day-to-day operations of these facilities, such as laundry, facility management and maintenance, water and wastewater treatments, power generation, communication systems, security and logistics. The company operates in active oil, metallurgical coal, liquefied natural gas and iron ore-producing regions. The company operates in three reportable business segments Canada, Australia and the United States.

Share on Social Networks: